Mutations in endoglin (ENG) and activin A receptor type II-like 1 (ACVRL1) genes are detected in approximately 90% of cases submitted to molecular diagnosis for clinical suspicion of HHT and cause HHT1 and HHT2, respectively [2,7,8,9]. The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.